Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 4/20 | 0.69 |
| ▸ | PPARD | Q03181 | 4/20 | 0.69 |
| ▸ | PPARA | Q07869 | 4/20 | 0.69 |
| ▸ | SYNJ2 | O15056 | 2/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | ABL1 | P00519 | 1/20 | 0.67 |
| ▸ | ALPL | P05186 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | ALPI | P09923 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | ALPG | P10696 | 1/20 | 0.67 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.67 |
| ▸ | RECQL | P46063 | 1/20 | 0.67 |
| ▸ | GALK1 | P51570 | 1/20 | 0.67 |
| ▸ | CASP7 | P55210 | 1/20 | 0.67 |
| ▸ | CASP6 | P55212 | 1/20 | 0.67 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.67 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.67 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24993777 | 0.82 | PRKCA (0.51) | PPARGPPARDPPARASYNJ2KDM4E | |
| SCHEMBL15773392 | 0.80 | SYNJ2 (1.00) | PPARGPPARDPPARASYNJ2KDM4E | |
| SCHEMBL17157084 | 0.80 | SYNJ2 (1.00) | PPARGPPARDPPARASYNJ2KDM4E | |
| SCHEMBL5320094 | 0.78 | TYR (0.71) | PPARGPPARDPPARASYNJ2KDM4E | |
| SCHEMBL16234564 | 0.78 | TYR (0.71) | PPARGPPARDPPARASYNJ2KDM4E | |
| SCHEMBL28971367 | 0.78 | TYR (0.71) | PPARGPPARDPPARASYNJ2KDM4E | |
| SCHEMBL329049 | 0.78 | TYR (0.71) | PPARGPPARDPPARASYNJ2KDM4E | |
| SCHEMBL16233068 | 0.78 | TYR (0.71) | PPARGPPARDPPARASYNJ2KDM4E | |
| Alnuside B SCHEMBL22796510 | 0.75 | PPARG (0.49) | PPARGPPARDPPARASYNJ2KDM4E | |
| Alnuside B SCHEMBL12672476 | 0.75 | PPARG (0.49) | PPARGPPARDPPARASYNJ2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4267103-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | Oriflame Cosmetics AG (CH) | 2023-11-01 | — | — | EP | claimed |
| US-20230270805-A1 | A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF | SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2023-08-31 | — | — | US | claimed |
| WO-2022135827-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | ORIFLAME COSMETICS AG (CH) | 2022-06-30 | — | — | WO | claimed |
| WO-2022035115-A1 | COMPOSITION FOR PREVENTION AND TREATMENT OF SKELETAL MUSCLE-RELATED DISEASES CONTAINING ALNUS JAPONICA EXTRACT OR COMPOUND ISOLATED THEREFROM AND USE THEREOF | 숙명여자대학교 산학협력단 | 2022-02-17 | — | — | WO | claimed |
| US-20250073156-A1 | Topical Compositions and Methods to Promote Optimal Dermal White Adipose Tissue Composition in Vivo | GALANIN IVAN (US) | 2025-03-06 | — | — | US | disclosed |
| US-12226517-B2 | Topical compositions and methods to promote optimal dermal white adipose tissue composition in vivo | GALANIN IVAN (US) | 2025-02-18 | — | — | US | disclosed |
| EP-4267103-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | Oriflame Cosmetics AG (CH) | 2023-11-01 | — | — | EP | disclosed |
| CN-116685341-A | Plant extracts for improving skin barrier function | 欧瑞莲化妆品股份有限公司 | 2023-09-01 | — | — | CN | disclosed |
| US-20230270805-A1 | A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF | SOOKMYUNG WOMEN'S UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2023-08-31 | — | — | US | disclosed |
| WO-2022135827-A1 | PLANT EXTRACTS FOR IMPROVING SKIN BARRIER FUNCTION | ORIFLAME COSMETICS AG (CH) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022035115-A1 | COMPOSITION FOR PREVENTION AND TREATMENT OF SKELETAL MUSCLE-RELATED DISEASES CONTAINING ALNUS JAPONICA EXTRACT OR COMPOUND ISOLATED THEREFROM AND USE THEREOF | 숙명여자대학교 산학협력단 | 2022-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230270805-A1 | A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF | MAPK6, MAPK13, PYGM | PPARG 1297/4885PPARD 1500/4885PPARA 1295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.